• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.40% Nasdaq Up0.02%

    Clovis Oncology, Inc. (CLVS)

    -NasdaqGS
    55.54 Down 1.10(1.94%) 9:38AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue -   -   13,625   -  
    Cost of Revenue -   -   -   -  
    Gross Profit -   -   13,625   -  
    Operating Expenses
    Research Development34,965  28,440  24,151  22,544  
    Selling General and Administrative6,155  6,126  6,142  5,950  
    Non Recurring -  400  8,406   -  
    Others -   -  3,409   -  
    Total Operating Expenses -   -  42,108   -  
    Operating Income or Loss (41,120) (34,966) (28,483) (28,494)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,770  270  (106)(657)
    Earnings Before Interest And Taxes(39,350)(34,696)(28,589)(29,151)
    Interest Expense -   -   -   -  
    Income Before Tax(39,350)(34,696)(28,589)(29,151)
    Income Tax Expense292  68  2,129  52  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(39,642)(34,764)(30,718)(29,203)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (39,642) (34,764) (30,718) (29,203)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (39,642) (34,764) (30,718) (29,203)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.